Healthcare Innovation January 18, 2023
Janette Wider

HHS, through CMS, announced in a Jan. 18 press release that it is taking new actions to reduce the incorrect use of antipsychotic medications and to bring greater transparency regarding citations to the public

According to a Jan. 18 press release, the U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), announced new actions to reduce the incorrect use of antipsychotic medications and to bring more transparency about nursing home citations to families. These actions are part of the efforts under President Biden’s initiative to improve nursing home transparency, safety and quality, and accountability.

The press release states that “Beginning this month, CMS will conduct targeted, off-site audits to determine whether nursing...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Healthcare System, HHS, Post-Acute Care, Provider, Safety
DEA, HHS issue another extension for telehealth controlled substance prescribing
Telehealth prescribing of controlled drugs extended through 2025
Trump's HHS nominee: 8 things to know
Are hospitals complying with price transparency rules? What an OIG report found.
Scientists Fear What's Next for Public Health if RFK Jr. Is Allowed to 'Go Wild'

Share This Article